Bladder Cancer Diagnosis, Therapeutics, and Management /

In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cance...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Lee, Cheryl T. (Editor), Wood, David P. (Editor)
Format: Electronic
Language:English
Published: Totowa, NJ : Humana Press, 2010.
Series:Current Clinical Urology
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-59745-417-9
LEADER 04117nam a22004455i 4500
001 9293
003 DE-He213
005 20130725193654.0
007 cr nn 008mamaa
008 100301s2010 xxu| s |||| 0|eng d
020 # # |a 9781597454179  |9 978-1-59745-417-9 
024 7 # |a 10.1007/978-1-59745-417-9  |2 doi 
050 # 4 |a RC870-923.2 
050 # 4 |a RC875-899.5 
072 # 7 |a MJS  |2 bicssc 
072 # 7 |a MED088000  |2 bisacsh 
082 0 4 |a 616.6  |2 23 
100 1 # |a Lee, Cheryl T.  |e editor. 
245 1 0 |a Bladder Cancer  |b Diagnosis, Therapeutics, and Management /  |c edited by Cheryl T. Lee, David P. Wood.  |h [electronic resource] : 
264 # 1 |a Totowa, NJ :  |b Humana Press,  |c 2010. 
300 # # |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
490 1 # |a Current Clinical Urology 
505 0 # |a Part I. Improving Bladder Cancer Staging -- Section 1. CIS -- Approach to CIS.-Fluorescent Cystoscopy -- Section 2. Understaging -- Restaging TURBT -- Understaging T2: Limitations of Pelvic Imaging -- MRI Endorectal Coil -- PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease -- Detection of Extravesical Disease: A Lack of Bladder Cancer Markers -- Identification of Nodal Metastases: The Role of Iron Oxide Enhanced MRI -- Presence and Significance of Micrometastases -- Part II. Optimizing Treatment of Localized Disease -- Section 1: Intravesical Therapy -- Peri-operative intravesical therapy -- BCG Refractory Disease -- Beyond BCG: Gemcitabine -- Beyond BCG: Taxanes -- Section 2: Cystectomy: Cancer Control and Organ Preservation -- Extended Lymph Node Dissection -- Prostate Capsule Sparing Cystectomy -- Preservation of Reproductive Organs in Women -- Nerve Sparing Cystectomy -- Quality of Care Indicators for Radical Cystectomy -- Continent Diversion: Problems and Solutions -- Continent Diversion: QOL of Orthotopic Diversion vs Ileal Conduit -- Voiding Dysfunction After Orthotopic Diversion -- Overcoming the Stigma of Complications of Continent Cutaneous Diversion -- Part III. Locally Advanced / Distant Disease: Multi-Modality treatment -- Neoadjuvant Chemotherapy: The New Standard -- Adjuvant Therapy: A Good Concept But Where s the Proof -- Beyond MVAC: New and Improved Chemotherapeutics -- Part IV: Next Steps: Translational Research -- The Role of Microarray Technologies in Bladder Cancer Management -- Development of Novel Agents / Targeted Therapies -- Tools for Study: National Databanking -- Vaccine Development -- Advances in Gene Therapy for Bladder Cancer. 
520 # # |a In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cancer care. Their work aims to spur innovative thoughts and approaches to common problems in the management of early stage and advanced disease. The book discusses at length the state of bladder cancer staging and the optimal treatment for localized disease. Additional sections review the applications of existing systemic therapies and look at the infrastructure needed to support translational research efforts. Groundbreaking and authoritative, Bladder Cancer: Moving the Field Forward, is the definitive text on the current state of bladder cancer care and a must have for all urologists and medical oncologists who wish to provide their patients with the most comprehensive care. 
650 # 0 |a Medicine. 
650 # 0 |a Urology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Urology/Andrology. 
700 1 # |a Wood, David P.  |e editor. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781588299888 
830 # 0 |a Current Clinical Urology 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-59745-417-9 
912 # # |a ZDB-2-SME 
950 # # |a Medicine (Springer-11650)